Added to YB: 2022-01-20
Pitch date: 2022-01-20
AMLX [bearish]
Amylyx Pharmaceuticals, Inc.
-97.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
Market Cap
$2.6B
Pitch Price
$20.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.77
P/E
-16.32
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Amylyx Pharmaceuticals Inc AMLX
A summary for this pitch has not been created yet.
Read full article (0 min)